Namandje Bumpus
Director · 2 filings · Latest: Jun 17, 2026
RECURSION PHARMACEUTICALS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
RXRX | Namandje Bumpus | Director | Jun 18, 2026 | Sale | $3.18 | 3,963 | $12.6K | 127,632 | |
RXRX | Bumpus Namandje | — | Jun 18, 2026 | Proposed Sale | $3.18 | 3,963 | $12.6K | — | |
RXRX | Namandje Bumpus | Director | Jun 3, 2026 | Sale | $3.54 | 4,386 | $15.5K | 43,171 | |
RXRX | Bumpus Namandje | — | Jun 3, 2026 | Proposed Sale | $3.54 | 4,386 | $15.5K | — |